ARS Pharmaceuticals, Inc.
Total Trades
89
Buys
7
Sells
57
Largest Trade
$1M+
Insiders
13
Institutional Funds
147
Inst. Value
$1M+
Activist Filings
27
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Scott Kathleen D. | CFO | SELL | $100K–$500K | 13K | $16.00 | Aug 21, 2024 |
| Scott Kathleen D. | CFO | EXERCISE | $15K–$50K | 13K | $1.50 | Aug 21, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $1M+ | 100K | $15.03 | Aug 21, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $1M+ | 100K | $15.03 | Aug 21, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $500K+ | 100K | $9.14 | Jun 13, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $500K+ | 100K | $9.14 | Jun 13, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $500K+ | 100K | $9.28 | Apr 17, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $500K+ | 100K | $9.28 | Apr 17, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $500K+ | 100K | $9.28 | Apr 10, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $500K+ | 100K | $9.28 | Apr 10, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 1.4M | $9.48 | Mar 27, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $500K+ | 98K | $9.12 | Mar 26, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $500K+ | 98K | $9.12 | Mar 26, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $15K–$50K | 2K | $9.03 | Mar 22, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $9.03 | Mar 22, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 4K | $9.02 | Mar 2, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $15K–$50K | 4K | $9.02 | Mar 2, 2024 |
| Tanimoto Sarina | CHIEF MEDICAL OFFI… | SELL | $500K+ | 99K | $9.02 | Feb 29, 2024 |
| Lowenthal Richard E | PRESIDENT AND CEO | SELL | $500K+ | 99K | $9.02 | Feb 29, 2024 |
| Fitzpatrick Alexander A | Chief Legal Officer | BUY | $100K–$500K | 86K | $3.71 | Oct 2, 2023 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 2.7M | $3.03 | Sep 25, 2023 |
| Shawver Laura | Director | SELL | $500K+ | 100K | $7.71 | Sep 6, 2023 |
| Shawver Laura | Director | EXERCISE | $100K–$500K | 100K | $1.27 | Sep 6, 2023 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 3.8M | $6.20 | Aug 31, 2023 |
| ORBIMED ADVISORS LLC | Director | BUY | $1M+ | 500K | $6.20 | Aug 31, 2023 |
| Thompson Peter A. | Director | BUY | $1M+ | 500K | $6.20 | Aug 31, 2023 |
| Shawver Laura | Director | SELL | $100K–$500K | 45K | $7.03 | Aug 7, 2023 |
| Shawver Laura | Director | EXERCISE | $50K–$100K | 45K | $1.27 | Aug 7, 2023 |
| Shawver Laura | Director | SELL | $100K–$500K | 55K | $7.12 | Aug 3, 2023 |
| Shawver Laura | Director | EXERCISE | $50K–$100K | 55K | $1.27 | Aug 3, 2023 |
| Shawver Laura | Director | SELL | $50K–$100K | 9K | $6.36 | Jul 8, 2023 |
| Shawver Laura | Director | EXERCISE | $1K–$15K | 9K | $1.27 | Jul 8, 2023 |
| Shawver Laura | Director | EXERCISE | $100K–$500K | 91K | $1.27 | Jul 7, 2023 |
| Shawver Laura | Director | SELL | $500K+ | 91K | $6.48 | Jul 7, 2023 |
| Shawver Laura | Director | EXERCISE | $100K–$500K | 100K | $1.27 | Jun 2, 2023 |
| Shawver Laura | Director | SELL | $500K+ | 100K | $6.84 | Jun 2, 2023 |
| Shawver Laura | Director | SELL | $500K+ | 144K | $5.42 | May 10, 2023 |
| Shawver Laura | Director | EXERCISE | $100K–$500K | 100K | $1.27 | May 10, 2023 |
| Scott Kathleen D. | CFO | BUY | $50K–$100K | 8K | $6.24 | Dec 1, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 147 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.9M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 8.3M | $1M+ | SH |
| Rubric Capital Management LP | 6.2M | $1M+ | SH |
| SR ONE CAPITAL MANAGEMENT, LP | 4.0M | $1M+ | SH |
| Aberdeen Group plc | 3.6M | $1M+ | SH |
| STATE STREET CORP | 3.2M | $1M+ | SH |
| Tyro Capital Management LLC | 2.0M | $1M+ | SH |
| Tyro Capital Management LLC | 2.0M | $1M+ | SH |
| Southpoint Capital Advisors LP | 1.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.3M | $1M+ | SH |
| Janney Montgomery Scott LLC | 1.3M | $1M+ | SH |
| LEVIN CAPITAL STRATEGIES, L.P. | 748K | $1M+ | SH |
| Nextech Invest, Ltd. | 661K | $1M+ | SH |
| BANK OF MONTREAL /CAN/ | 643K | $1M+ | SH |
| CenterBook Partners LP | 568K | $1M+ | SH |
| GENERAL AMERICAN INVESTORS CO INC | 560K | $1M+ | SH |
| Third Point LLC | 556K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 456K | $1M+ | SH |
| Alyeska Investment Group, L.P. | 419K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 13, 2026
6.3%
6.2M shares
SC 13G · Jan 21, 2026
5.1%
5.0M shares
SC 13D/A · Oct 2, 2025
11.1%
10.9M shares
SC 13D/A · Aug 1, 2025
3.9%
3.8M shares
SC 13D/A · Jul 22, 2025
4.4%
4.3M shares
SC 13D/A · Jul 2, 2025
5.0%
4.9M shares
SC 13D/A · Mar 24, 2025
5.4%
5.3M shares
The Pratik Shah Living Trust dated June 15, 2011(1) 2.
SC 13D/A · Jun 18, 2024
5.4%
5.2M shares
The Pratik Shah Living Trust dated June 15, 2011(1) 2.
SC 13D/A · Jun 11, 2024
6.8%
6.6M shares
SC 13D/A · Mar 29, 2024
11.3%
10.9M shares
SC 13D/A · Sep 25, 2023
9.9%
9.5M shares
SC 13D/A · Sep 1, 2023
4.5%
4.3M shares
SC 13D · Aug 31, 2023
7.1%
6.8M shares
SC 13G/A · Feb 14, 2023
2.0%
1.9M shares
SC 13G/A · Feb 13, 2023
2.2%
2.0M shares
SC 13D/A · Nov 30, 2022
8.3%
7.8M shares
SC 13D · Nov 21, 2022
9.1%
8.6M shares
SC 13D · Nov 18, 2022
5.9%
5.5M shares
The Pratik Shah Living Trust dated June 15, 2011(1)
SC 13D · Nov 18, 2022
10.8%
10.2M shares
Richard E. Lowenthal, M.S., MSEL
SC 13D · Nov 18, 2022
7.9%
7.4M shares
SC 13D · Nov 18, 2022
6.7%
6.3M shares
SC 13G · Jul 15, 2022
5.4%
1.9M shares
SC 13G/A · Feb 14, 2022
0 shares
SC 13G/A · Feb 14, 2022
5.0%
1.7M shares
SC 13G/A · Feb 14, 2022
3.0%
1.1M shares
Wasatch Advisors, Inc. 87-0319391
SC 13G · Feb 10, 2022
5.1%
1.8M shares
U.S. Venture Partners XII, L.P. (“USVP XII”)
SC 13D · Jan 27, 2022
0.0%
0 shares